Treatment with α2-adrenoceptor antagonist, 2-methoxy idazoxan, protects 6-hydroxydopamine-induced Parkinsonian symptoms in rats: neurochemical and behavioral evidence
- 5 October 2004
- journal article
- research article
- Published by Elsevier in Behavioural Brain Research
- Vol. 154 (2) , 353-363
- https://doi.org/10.1016/j.bbr.2004.03.002
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- RX 821002 as a Tool for Physiological Investigation of α2-AdrenoceptorsCNS Drug Reviews, 2006
- Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's diseasePublished by Elsevier ,2001
- Subthalamic infusion of an NMDA antagonist prevents basal ganglia metabolic changes and nigral degeneration in a rodent model of Parkinson's diseaseAnnals of Neurology, 2001
- Neuronal Gene Expression in the Waking State: A Role for the Locus CoeruleusScience, 1996
- Locus coeruleus lesions potentiate neurotoxic effects of MPTP in dopaminergic neurons of the substantia nigraBrain Research, 1994
- Noradrenergic activation of immediate early genes in rat cerebral cortexMolecular Brain Research, 1991
- Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in ratNeuropharmacology, 1987
- Adrenergic receptors in Parkinson's diseaseBrain Research, 1984
- Norepinephrine-Dopamine Interactions and BehaviorScience, 1977
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973